{"name":"Catalyst Pharmaceuticals, Inc.","slug":"catalyst-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNZzV2dTBkeVZPVVR2RkJzM2RoVzh2M05hdWhOb0N3SDlCMWVvc2toZ2MycFFZbUp0SExxazBjSnNpZ1lfTHdrNjRNYXZacERKbjh5dEF1T0VuLXp4UEd3YlJTc2t2ZVhDWTVyNEdLREVoRGNfVElzSlAtb01lcDZ4dUh2eXJ2M0tKZWFEd0hQYXZhcGFPSWRlSzhhVUd1U2lfT3BiQnhLdkluRk95ZXBZWExDWERJYnk1YkNnZjRiTXZYTDQ?oc=5","date":"2026-03-18","type":"trial","source":"Stock Titan","summary":"Patent trial on Catalyst (NASDAQ: CPRX) FIRDAPSE® patents delayed to May 18, 2026 - Stock Titan","headline":"Patent trial on Catalyst (NASDAQ: CPRX) FIRDAPSE® patents delayed to May 18, 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOV21qV1AwLW1OY2gyR2NGckxrb1YwZGNrUUV4T2k0NjVwalNEVDJrVjBwWnBxZmh5aWxLeHlOdEdPWUhHbE5nU1FSUWRBV3dWVzBCSHVlTkFfVUp0a2hZaTRFZkhicWJYajNzb28zSE9xaDNNMTBvR09sSHBPWFpYSVlJNmNrclZzekloNDJmZm5sTVJyWjlzdGx3WW1iNk1OaXNNWlJfUnVLTlZBMm5yYmtGLW9ZbHhh?oc=5","date":"2026-03-18","type":"trial","source":"Stock Titan","summary":"Catalyst Pharmaceuticals (NASDAQ: CPRX) FIRDAPSE patent trial pushed to May 2026 - Stock Titan","headline":"Catalyst Pharmaceuticals (NASDAQ: CPRX) FIRDAPSE patent trial pushed to May 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOWmRiWEpDUU1uYUxHS09kSEZtTTVTVzYxTTlGeWNFbEFqYmRMTjB2SVI3TGtNT0xPemRDWW9YUU9wQTRnZmo0S2JzaGNJaHFIQW9HamxiVXFPQkU0U1dmWEIxSU9WWF9pSDhMMEZkOHFLSjZEYVh3X1FoXzdWN29mSVVQb3IwdTVZZ18yWDVYSE5sWmF0UnB2eVNjbE1oUDd0dHF5RDF3aFVmN3VJNkE4OVNRSTFfbVpiUWhhSUlwblk?oc=5","date":"2026-03-06","type":"trial","source":"Stock Titan","summary":"Real-world Duchenne data: how a novel steroid is used in care - Stock Titan","headline":"Real-world Duchenne data: how a novel steroid is used in care","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPZGFDeEtITEVMQXV0ZHczcEx1NW4ybWx5X1BLNE1ZaGM1YXZJcjhaVXQ0S0Q1OEhBNW9PVkRkbUlQV3VYeW9ybHlTWnBaN2dKMkVXNF9iUFdzUnphSEJCODZzc2ZzenAzazRTWDdvRWg5OW9jR0FUWDA1WU5VcWxvNEY0N1Z0MjB1RFdrNko2dUplVDhJMHgzRXRPbmtBSmQ0QVJJMTY2cFhMZFNGMno4M2t1WHllRzEtY3FVZU9qSjlvREdjVmJTaEFZRnVYQTVmRWk3Y3FMSVlxM2VQ?oc=5","date":"2026-03-04","type":"pipeline","source":"PR Newswire","summary":"Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight - PR Newswire","headline":"Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQSG1Lb1d5Nk54Z0dlOU1JMUR5VmpycURvVXZjajlCTFgwb3g2bV9tcmloZ1A1aF9IWTlZMDhfZThvcjZfNjJjVngyWWRnQmJ6SXJiWUprSWlSUTVQVm5CNFlTQlhmRFRFb2ZERDAzQnBkcklTblNsenAyTGtMTzA5MFlTckJvLUI5NnJfY2YzMm9rblU0UGQ4a1N5aDQ3T0ZxMFNHdWJRRXhTeE5Wbkt1UGp1M0tad0I3dFotYmtR?oc=5","date":"2026-02-19","type":"regulatory","source":"Seeking Alpha","summary":"Catalyst Pharmaceuticals: Clear Path Forward For Growth In 2 FDA-Approved Drugs (CPRX) - Seeking Alpha","headline":"Catalyst Pharmaceuticals: Clear Path Forward For Growth In 2 FDA-Approved Drugs (CPRX)","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPMDBMbWJTUTNiM3Z5Yk03WklteTY1WDE5M3R0RmlabFVyX2NNRnFOOG5scnJTT1V5Q0E3THlkMzktMGdXdHFnbW1yVVM2TDZpUEF1M3N3d2toWkZiSW12WWR6ZTZjUVRwMFFrUjlpU29sTVZFS2ZLdFhzQXhIYmhLVEluajB2RWkwUnY0ZnVKUWJjSVRmVHFz?oc=5","date":"2026-02-18","type":"earnings","source":"Yahoo Finance","summary":"Analysts Estimate Catalyst Pharmaceutical (CPRX) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance","headline":"Analysts Estimate Catalyst Pharmaceutical (CPRX) to Report a Decline in Earnings: What to Look Out for","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPa3V5ZzR6ZkJfUFVxMDF1MU10MzJ2MFBYYU9oMmUyQ0cwTjFEWUN2UVlRSkNUS18wZEhQeEJsZjVOdGhzS053NHdzY3lxcW1BSmtIZ2FfTy1aT2MwTnV4cTNRX2VyTkxnZ29kNGpsMHE4Y182d1dIQ2ItSU5qZndPTlZkLWZuUUVp?oc=5","date":"2025-12-18","type":"pipeline","source":"Yahoo Finance","summary":"Assessing Catalyst Pharma After 600% Surge and Rare Disease Expansion in 2025 - Yahoo Finance","headline":"Assessing Catalyst Pharma After 600% Surge and Rare Disease Expansion in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQaF85NHZ5NzZQcXRfZkN2MENZSTlvaTh5VVh6cnBCMXR1MVR4NHhKcUNhMnRTUzV0V2JMUGc0S1pkU1RsMk9RSjY5eDJsM0xTYTFlNTFmVUJjdGt0WlVJUF9xTFh4bHlkQlJVMnZDME5ZMm10T1pCeE0yTTM3ZWM4SjY3cXdyNTZka3Qxa1F6ZDBuTTNhOWxV?oc=5","date":"2025-11-06","type":"pipeline","source":"Finimize","summary":"Catalyst Pharmaceuticals Rides Organic Growth To Record Results - Finimize","headline":"Catalyst Pharmaceuticals Rides Organic Growth To Record Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNdE1UbDZLcE55OVhoQjhQandsMkNTZDJ1VjlndEtlQlJPclZQVEtxN3BXOHd6MmVxa0VWZDRaQ2Q2c1BzQ0V2eUJ4ajR5M3RUbjk3X252cFFwS0lBVC1Xa3RQbC1NSEFackFfRUduUVRzZ0JxVG9zZHVMc0Jiby04Q2JnVlJ2OTB6N1FheHQtZVFhVTI1Q25vZWNvNkN4d3ZGMkxHUlEySQ?oc=5","date":"2025-10-29","type":"pipeline","source":"Seeking Alpha","summary":"Catalyst Pharmaceuticals: Cash Rich, But Running Out Of Catalysts (NASDAQ:CPRX) - Seeking Alpha","headline":"Catalyst Pharmaceuticals: Cash Rich, But Running Out Of Catalysts (NASDAQ:CPRX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPOWdqNld6WXF1cVZjbThZX1BSRjRkdmpJNjVZbzVpUTJnUFVHeHpJclc1Q0NfbWg2aE9VcmlTRXM5X2VLQ3R4cUZYaUZMMjdkQkZYeW9JSjZNanNCeVBuZU1nWnNiY0VpdGRvZnVpVE94OVRYZ2lNdVJRTjgyajVmdXR3WnNTdXA0TGFxMA?oc=5","date":"2025-10-24","type":"pipeline","source":"Yahoo Finance","summary":"Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock - Yahoo Finance","headline":"Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPRWlsbTNjLUIzdnZVbzdvQldkaWU4TEpEODRhbDlsYnpDeE9vbzJrQlpJa2ctZjF3WkRXdHFFWVBNN29jTy1SU0FTa0ZNUE1aWmw2dl85WDliVk9jY2VzR1ZxQjN4M29VTl92cks4eGQ5bFpFRUFBdTNsRkRMTzBpS0dUdm9TbzROYUVWUUQzZnY3b25fdW1hYi1ueDVJdUN4SlB4LVNoWnpwU3RXVHEyNnZfanVGX2xZaFNrOVpfY1c5a2dEblV1THN4ZHVHWU9VbE5sVzNaV0hHYTg0ODBndA?oc=5","date":"2025-10-01","type":"pipeline","source":"globenewswire.com","summary":"Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program - globenewswire.com","headline":"Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxNQUkzZXFpOTdOak1FRWZjZVBkZzNoaDQtSmVZcm9URVFRc0E5WFpLUTFyZFowNHBfOUtQU04yX0xDVGl6ZE5sX25NbE50TndZV2QybE4wampzNWFhUzVRV0xFTDZDT0J2ckVjb2ZaUVJtbnBmam1tRExaQnRBdTBRelN3ME5QdkNDOWQ5aVYzWEd0MVVmRlFua0NPTFlBalNIS0JnYmhmNFJOS01NZnJfZ0FHT1J5anp6eGtjRmZZUURjMExFQi1jOS1Ya3hMQXNOV1I5Q1JaWXFKdnZwcnZXZTZLdTY1NnRPVzgzT1B3eXpVTUtValFaUTBTdVh3VXFVLXcxbUtwS1hCWWowRGdjaWVGLWNPT1o3SUpiODJ6N2JqNWVZM0s0?oc=5","date":"2025-08-26","type":"pipeline","source":"globenewswire.com","summary":"UPDATED- Catalyst Pharmaceuticals Announces Settlement of - globenewswire.com","headline":"UPDATED- Catalyst Pharmaceuticals Announces Settlement of","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}